EP 1230364 A2 20020814 - COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
Title (en)
COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND DIAGNOSE VON PROSTATAKREBS
Title (fr)
COMPOSITIONS ET METHODES DE TRAITEMENT ET DE DIAGNOSTIC DU CANCER DE LA PROSTATE
Publication
Application
Priority
- US 0030904 W 20001109
- US 43931399 A 19991112
- US 44368699 A 19991118
Abstract (en)
[origin: WO0134802A2] Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are disclosed. Compositions may comprise one or more prostate-specific proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a prostate-specific protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on detecting a prostate-specific protein, or mRNA encoding such a protein, in a sample are also provided.
IPC 1-7
C12N 15/12; C12N 15/62; C12N 15/11; C12N 1/21; C12N 5/10; C07K 14/47; C07K 16/18; C07K 19/00; A61K 38/17; A61K 31/70; A61K 39/395; A61K 48/00; G01N 33/68; C12Q 1/68
IPC 8 full level
G01N 33/53 (2006.01); A61K 31/711 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); C07K 14/11 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/07 (2010.01); C12N 5/0783 (2010.01); C12N 5/0784 (2010.01); C12N 5/0786 (2010.01); C12N 5/09 (2010.01); C12N 5/10 (2006.01); C12N 9/64 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); G01N 33/566 (2006.01); G01N 33/574 (2006.01); G01N 33/577 (2006.01)
CPC (source: EP)
A61K 39/4611 (2023.05); A61K 39/464494 (2023.05); A61P 35/00 (2018.01); A61P 35/04 (2018.01); C07K 14/005 (2013.01); C12N 9/6424 (2013.01); A61K 39/00 (2013.01); A61K 2039/53 (2013.01); C07K 2319/00 (2013.01); C12N 2760/16022 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0134802 A2 20010517; WO 0134802 A3 20020404; WO 0134802 A9 20020808; AU 1656501 A 20010606; CA 2391369 A1 20010517; EP 1230364 A2 20020814; JP 2004537252 A 20041216
DOCDB simple family (application)
US 0030904 W 20001109; AU 1656501 A 20001109; CA 2391369 A 20001109; EP 00979155 A 20001109; JP 2001537498 A 20001109